menu
    • menu

    Company profile for Quanta Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Quanta Therapeutics is pioneering allosteric modulation to directly restore conformational control of active RAS signaling at the cell membrane to inhibit the full scope of RAS-driven cancer types. Our team applies deep biologic insight, unique protein conformation detection technology and sophisticated medicinal chemistry expertise to develop novel small molecules as first-in-class precision medicines breaking the resistance ...
    Quanta Therapeutics is pioneering allosteric modulation to directly restore conformational control of active RAS signaling at the cell membrane to inhibit the full scope of RAS-driven cancer types. Our team applies deep biologic insight, unique protein conformation detection technology and sophisticated medicinal chemistry expertise to develop novel small molecules as first-in-class precision medicines breaking the resistance paradigms of targeted therapy in oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Quanta TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Two Tower Place, 17th Floor South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.quantatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/quanta-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034
    Quanta Therapeutics Presents Positive Phase 1 Data for QTX3034

    24 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/24/3172963/0/en/Quanta-Therapeutics-Presents-Positive-Phase-1-Data-for-QTX3034-an-Oral-G12D-Preferring-Multi-KRAS-Inhibitor-in-Patients-with-Advanced-Solid-Tumors.html

    GLOBENEWSWIRE
    24 Oct 2025
    Share Share
    Quanta Therapeutics Unveils QTX3034, Clinical Data at Confernece
    Quanta Therapeutics Unveils QTX3034, Clinical Data at Confernece

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165683/0/en/Quanta-Therapeutics-Announces-First-Clinical-Data-Presentation-for-QTX3034-an-Oral-G12D-Preferring-Multi-KRAS-Inhibitor-at-2025-AACR-NCI-EORTC-International-Conference-on-Molecular.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    Quanta Announces New Leadership and Clinical Program Progress
    Quanta Announces New Leadership and Clinical Program Progress

    23 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/23/3120181/0/en/Quanta-Announces-Leadership-Team-Appointment-and-Highlights-Clinical-Program-Progress.html

    GLOBENEWSWIRE
    23 Jul 2025
    Share Share
    Quanta Presents Late-Breaking Data for QTX3544 at AACR Meeting
    Quanta Presents Late-Breaking Data for QTX3544 at AACR Meeting

    28 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/28/3069151/0/en/Quanta-Therapeutics-Presents-Late-Breaking-Data-for-QTX3544-an-Oral-G12V-Preferring-Multi-KRAS-Inhibitor-at-AACR-Annual-Meeting-2025.html

    GLOBENEWSWIRE
    28 Apr 2025
    Share Share
    Quanta Therapeutics Announces QTX3544 Presentation at AACR 2025
    Quanta Therapeutics Announces QTX3544 Presentation at AACR 2025

    25 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/25/3049185/0/en/Quanta-Therapeutics-Announces-Late-Breaking-Presentation-of-QTX3544-an-Oral-G12V-Preferring-Multi-KRAS-Inhibitor-at-AACR-Annual-Meeting-2025.html

    GLOBENEWSWIRE
    25 Mar 2025
    Share Share
    Quanta Gets IND Clearance For QTX3544 & Shares Pipeline Updates
    Quanta Gets IND Clearance For QTX3544 & Shares Pipeline Updates

    08 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/08/3006334/0/en/Quanta-Announces-IND-Clearance-by-U-S-FDA-for-QTX3544-an-Oral-G12V-Preferring-Multi-KRAS-Inhibitor-and-Other-Pipeline-Updates.html

    GLOBENEWSWIRE
    08 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search